In the upcoming case of Teva Pharmaceuticals v. Sandoz, the U.S. Supreme Court will address how much deference the appellate court should afford to a trial court's claim construction ruling. The effect of this decision will be far-reaching, as how claims are construed can determine whether a patent is infringed or not infringed, valid or invalid.
CITATION STYLE
Fogel, L. E., & Ray, C. J. (2015, January 1). Teva pharmaceuticals v. sandoz: Availability of generic glatiramer acetate and the impact to patent litigation claim construction. Expert Opinion on Therapeutic Patents. Informa Healthcare. https://doi.org/10.1517/13543776.2014.977866
Mendeley helps you to discover research relevant for your work.